Foo Fang Shawn, Stiles Martin K, Lee Mildred, Looi Khang-Li, Clare Geoffrey C, Webber Matthew, Boddington Dean, Jackson Rod, Poppe Katrina K, Kerr Andrew J
Department of Cardiology, Middlemore Hospital, Otahuhu, Auckland, New Zealand.
Department of Cardiology, Waikato Hospital, Hamilton, New Zealand.
Intern Med J. 2022 Apr;52(4):614-622. doi: 10.1111/imj.15103.
Implant rates for cardiac implantable electronic devices (CIED), including permanent pacemakers (PPM) and implantable cardioverter defibrillators (ICD), have increased globally in recent decades.
This is the first national study providing a contemporary analysis of national CIED implant trends by sex-specific age groups over an extended period.
Patient characteristics and device type were identified for 10 years (2009-2018) using procedure coding in the National Minimum Datasets, which collects all New Zealand (NZ) public hospital admissions. CIED implant rates represent implants/million population.
New PPM implant rates increased by 4.6%/year (P < 0.001), increasing in all age groups except patients <40 years. Males received 60.1% of new PPM implants, with higher implant rates across all age groups compared with females. The annual increase in age-standardised implant rates was similar for males and females (3.4% vs 3.0%; P = 0.4). By 2018 the overall PPM implant rate was 538/million. New ICD implant rates increased by 4.2%/year (P < 0.001), increasing in all age groups except patients <40 and ≥ 80 years. Males received 78.1% of new ICD implants, with higher implant rates across all age groups compared to females. The annual increase in age-standardised implant rates was higher in males compared with females (3.5% vs 0.7%; P < 0.001). By 2018 the overall ICD implant rate was 144/million.
CIED implant rates have increased steadily in NZ over the past decade but remain low compared with international benchmarks. Males had substantially higher CIED implant rates compared with females, with a growing gender disparity in ICD implant rates.
近几十年来，包括永久性起搏器（PPM）和植入式心脏复律除颤器（ICD）在内的心脏植入式电子设备（CIED）的植入率在全球范围内有所上升。
这是第一项全国性研究，对特定性别年龄组在较长时期内的全国CIED植入趋势进行当代分析。
利用国家最低数据集的程序编码确定了10年（2009 - 2018年）的患者特征和设备类型，该数据集收集了所有新西兰公立医院的入院病例。CIED植入率以每百万人口的植入数表示。
新的PPM植入率每年增加4.6%（P < 0.001），除40岁以下患者外，所有年龄组的植入率均有所增加。男性接受了60.1%的新PPM植入，与女性相比，所有年龄组的植入率都更高。男性和女性年龄标准化植入率的年增长率相似（3.4%对3.0%；P = 0.4）。到2018年，总体PPM植入率为每百万538例。新的ICD植入率每年增加4.2%（P < 0.001），除40岁以下和80岁及以上患者外，所有年龄组的植入率均有所增加。男性接受了78.1%的新ICD植入，与女性相比，所有年龄组的植入率都更高。男性年龄标准化植入率的年增长率高于女性（3.5%对0.7%；P < 0.001）。到2018年，总体ICD植入率为每百万144例。
在过去十年中，新西兰的CIED植入率稳步上升，但与国际基准相比仍然较低。男性的CIED植入率明显高于女性，ICD植入率的性别差距在不断扩大。
